The settlement also says Teva will supply the city with $20 million worth of generic Narcan, the brand name for a nasal spray used for opioid overdoses, over the next decade. Teva said the decision to settle “is not an admission of any liability or wrongdoing.”
From January to May, Teva has settled opioid cases with four states for about $378 million, according to Bloomberg.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
